Abstract:Rod tetrameric arrestin 1 (tet-ARR1), stored in the outer nuclear layer/inner segments in the dark, modulates photoreceptor synaptic activity; light exposure stimulates a reduction via translocation to the outer segments for terminating G-protein coupled phototransduction signaling. Here, we test the hypothesis that intraretinal spin-lattice relaxation rate in the rotating frame (1/T1r), an endogenous MRI contrast mechanism, has high potential for evaluating rod tet-ARR1 and its reduction via translocation. Da… Show more
“…Thus, at the present resolution, we previously demonstrated that MRI can distinguish rod inner segment from outer segment based on the light-evoked expansion of the subretinal space in mice and rats, as well as, for example, (1) inner from outer retina manganese uptake as a function of light, (2) DIL-induced suppression of only inner retinal manganese uptake, and (3) the outer nuclear layer-only tetrameric visual arrestin 1 and its reduction via light-evoked translocation. 28,29,50,51 These examples strongly support our claim that the resolution of MRI is sufficient for extracting meaningful layer-specific functional data in vivo. In all cases, animals were humanely euthanized as detailed in our IACUCapproved protocol.…”
Section: Mri Proceduressupporting
confidence: 69%
“…14,[23][24][25][26][27] However, subsequent studies have not found any evidence for a visual cycle defect in diabetic mice. 28 Thus, the mechanism by which 11-cis-retinaldehyde exerts its beneficial action in the diabetic mouse retina is still unclear.…”
PURPOSE. Diabetes appears to induce a visual cycle defect because rod dysfunction is correctable with systemic treatment of the visual cycle chromophore 11-cis-retinaldehyde. However, later studies have found no evidence for visual cycle impairment. Here, we further examined whether photoreceptor dysfunction is corrected with 11-cis-retinaldehyde. Because antioxidants correct photoreceptor dysfunction in diabetes, the hypothesis that exogenous visual chromophores have antioxidant activity in the retina of diabetic mice in vivo was tested.METHODS. Rod function in 2-month-old diabetic mice was evaluated using transretinal electrophysiology in excised retinas and apparent diffusion coefficient (ADC) MRI to measure light-evoked expansion of subretinal space (SRS) in vivo. Optokinetic tracking was used to evaluate cone-based visual performance. Retinal production of superoxide free radicals, generated mostly in rod cells, was biochemically measured with lucigenin. Diabetic mice were systemically treated with a single injection of either 11-cis-retinaldehyde, 9-cisretinaldehyde (a chromophore surrogate), or all-trans-retinaldehyde (the photoisomerization product of 11-cis-retinaldehyde).RESULTS. Consistent with previous reports, diabetes significantly reduced (1) dark-adapted rod photo responses (transretinal recording) by~18%, (2) rod-dominated light-stimulated SRS expansion (ADC MRI) by~21%, and (3) cone-dominated contrast sensitivity (using optokinetic tracking [OKT]) by~30%. Both 11-cis-retinaldehyde and 9-cis-retinaldehyde largely corrected these metrics of photoreceptor dysfunction. Higher-than-normal retinal superoxide production in diabetes by~55% was also significantly corrected following treatment with 11-cis-retinaldehyde, 9-cis-retinaldehyde, or all-trans-retinaldehyde.CONCLUSIONS. Collectively, data suggest that retinaldehydes improve photoreceptor dysfunction in diabetic mice, independent of the visual cycle, via an antioxidant mechanism.
“…Thus, at the present resolution, we previously demonstrated that MRI can distinguish rod inner segment from outer segment based on the light-evoked expansion of the subretinal space in mice and rats, as well as, for example, (1) inner from outer retina manganese uptake as a function of light, (2) DIL-induced suppression of only inner retinal manganese uptake, and (3) the outer nuclear layer-only tetrameric visual arrestin 1 and its reduction via light-evoked translocation. 28,29,50,51 These examples strongly support our claim that the resolution of MRI is sufficient for extracting meaningful layer-specific functional data in vivo. In all cases, animals were humanely euthanized as detailed in our IACUCapproved protocol.…”
Section: Mri Proceduressupporting
confidence: 69%
“…14,[23][24][25][26][27] However, subsequent studies have not found any evidence for a visual cycle defect in diabetic mice. 28 Thus, the mechanism by which 11-cis-retinaldehyde exerts its beneficial action in the diabetic mouse retina is still unclear.…”
PURPOSE. Diabetes appears to induce a visual cycle defect because rod dysfunction is correctable with systemic treatment of the visual cycle chromophore 11-cis-retinaldehyde. However, later studies have found no evidence for visual cycle impairment. Here, we further examined whether photoreceptor dysfunction is corrected with 11-cis-retinaldehyde. Because antioxidants correct photoreceptor dysfunction in diabetes, the hypothesis that exogenous visual chromophores have antioxidant activity in the retina of diabetic mice in vivo was tested.METHODS. Rod function in 2-month-old diabetic mice was evaluated using transretinal electrophysiology in excised retinas and apparent diffusion coefficient (ADC) MRI to measure light-evoked expansion of subretinal space (SRS) in vivo. Optokinetic tracking was used to evaluate cone-based visual performance. Retinal production of superoxide free radicals, generated mostly in rod cells, was biochemically measured with lucigenin. Diabetic mice were systemically treated with a single injection of either 11-cis-retinaldehyde, 9-cisretinaldehyde (a chromophore surrogate), or all-trans-retinaldehyde (the photoisomerization product of 11-cis-retinaldehyde).RESULTS. Consistent with previous reports, diabetes significantly reduced (1) dark-adapted rod photo responses (transretinal recording) by~18%, (2) rod-dominated light-stimulated SRS expansion (ADC MRI) by~21%, and (3) cone-dominated contrast sensitivity (using optokinetic tracking [OKT]) by~30%. Both 11-cis-retinaldehyde and 9-cis-retinaldehyde largely corrected these metrics of photoreceptor dysfunction. Higher-than-normal retinal superoxide production in diabetes by~55% was also significantly corrected following treatment with 11-cis-retinaldehyde, 9-cis-retinaldehyde, or all-trans-retinaldehyde.CONCLUSIONS. Collectively, data suggest that retinaldehydes improve photoreceptor dysfunction in diabetic mice, independent of the visual cycle, via an antioxidant mechanism.
“…Retinyl esters participate in 11-cis-retinal formation (49) and are shown herein to accumulate to supranormal levels in diabetic retina, suggesting an impairment of retinoid dynamics in diabetic mice. However, other investigators (58) have not found evidence of abnormal visual cycle activity in diabetes. Maintenance of the visual cycle requires support from numerous mitochondria in photoreceptor cells, and our previous evidence (17,37) suggests that much of the superoxide generated by the retina in diabetes is generated by such mitochondria.…”
Background:The development of diabetic retinopathy (DR) is incompletely understood. Administered retinylamine is stored in the retinal pigmented epithelium (RPE) where it affects the ocular visual cycle. Results: Retinylamine inhibited vascular and neural lesions of early DR. Conclusion: Both the RPE and visual cycle are novel targets for the inhibition of DR. Significance: Vision-related processes can contribute to DR.
“…Thus, MRI evaluates the same set of rod cells for compartment-specific function in vivo using different types of acquisitions (see below for details; summarized in Fig. 4) (Berkowitz et al, , 2015a(Berkowitz et al, , 2015cBissig and Berkowitz, 2012). In addition, four "free" metrics are also obtained: retinal and choroidal thickness, and light-dependent expansion of the inner retinal circulation and choroid (Fig.…”
Section: Breakthroughmentioning
confidence: 99%
“…Thus, two additional MRI indices of rod cell functione measured without administration of exogenous contrast agents e have been developed to complement MEMRI and to facilitate translation of MRI of retinal function into humans. These methods are i) apparent diffusion coefficient (ADC) MRI, which measures light-evoked expansion of both SRS [controlled in part by the photoreceptors and in part by the retinal pigment epithelium (RPE)] and of the choroid (Berkowitz et al, 2015a;Bissig and Berkowitz, 2012), and ii) measurement of the spin-lattice relaxation rate in the rotating-frame (1/T1r) which evaluates lightstimulated rod arrestin and its translocation, together with retinal vessel expansion (Berkowitz et al, 2015c). As summarized in Fig.…”
Section: Non-memri Assays Of Rod Cell Functionmentioning
Rod cell oxidative stress is a major pathogenic factor in retinal disease, such as diabetic retinopathy (DR) and retinitis pigmentosa (RP). Personalized, non-destructive, and targeted treatment for these diseases remains elusive since current imaging methods cannot analytically measure treatment efficacy against rod cell compartment-specific oxidative stress in vivo. Over the last decade, novel MRI-based approaches that address this technology gap have been developed. This review summarizes progress in the development of MRI since 2006 that enables earlier evaluation of the impact of disease on rod cell compartment-specific function and the efficacy of anti-oxidant treatment than is currently possible with other methods. Most of the new assays of rod cell compartment-specific function are based on endogenous contrast mechanisms, and this is expected to facilitate their translation into patients with DR and RP, and other oxidative stress-based retinal diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.